PT  - JOURNAL ARTICLE
AU  - Martina Favero
AU  - Gianpaolo Scalia Tomba
AU  - Tom Britton
TI  - Modelling preventive measures and their effect on generation times in emerging epidemics
AID  - 10.1101/2022.01.24.22269757
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.24.22269757
4099  - http://medrxiv.org/content/early/2022/01/24/2022.01.24.22269757.short
4100  - http://medrxiv.org/content/early/2022/01/24/2022.01.24.22269757.full
AB  - We present a stochastic epidemic model to study the effect of various preventive measures, such as uniform reduction of contacts and transmission, vaccination, isolation, screening and contact tracing, on a disease outbreak in a homogeneously mixing community. The model is based on an infectivity process, which we define through stochastic contact and infectiousness processes, so that each individual has an independent infectivity profile. In particular, we monitor variations of the reproduction number and of the distribution of generation times. We show that some interventions, i.e. uniform reduction and vaccination, affect the former while leaving the latter unchanged, whereas other interventions, i.e. isolation, screening and contact tracing, affect both quantities. We provide a theoretical analysis of the variation of these quantities, and we show that, in practice, the variation of the generation time distribution can be significant and that it can cause biases in the estimation of basic reproduction numbers. The framework, because of its general nature, captures the properties of many infectious diseases, but particular emphasis is on COVID-19, for which numerical results are provided.Competing Interest StatementThe authors have declared no competing interest.Funding StatementT.B. and M.F. are grateful to the Swedish Research Council (grant 2020-04744) for financial support. G.S.T. acknowledges the MIUR Excellence Department Project awarded to the Department of Mathematics, University of Rome Tor Vergata (CUP E83C18000100006)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon request to the authors